Dapirolizumab

1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

Dapirolizumab is a PEG-free antigen-binding (Fab') fragment that binds CD40L (CD154) and lacks a functional Fc domain. Dapirolizumab inhibits CD40L-dependent immune responses without causing thrombotic complications and can be used in research related to systemic lupus erythematosus.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.66%
  • No. CAS: 2235418-88-7
  • Peso molecular:145.5 kDa
  • Almacenamiento:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00